Back to Results
First PageMeta Content
Androgens / Dutasteride / GlaxoSmithKline / Organofluorides / Tamsulosin / 5-alpha-reductase inhibitor / Dihydrotestosterone / Benign prostatic hyperplasia / Prostate cancer / Medicine / Chemistry / Lactams


• Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema) to AVODART or other 5α-reductase inhibitors. (4)
Add to Reading List

Document Date: 2010-09-09 19:11:22

Open Document

File Size: 307,40 KB

Share Result on Facebook

Company

Placebo Group / Any Treatment Group / GlaxoSmithKline / /

Currency

pence / /

Event

FDA Phase / Product Recall / Product Issues / /

IndustryTerm

food / /

MedicalCondition

hypospadias / Cancer / BPH / Cardiac Failure / Carcinogenesis / acute urinary retention / ejaculation disorder / urticaria / angioedema / ejaculation disorders / clinically significant hypersensitivity / Hypersensitivity / benign prostatic hyperplasia / irritation / urological diseases / deficiency / dizziness / prostate cancer / pruritus / Other Urological Diseases / impotence / rash / breast disorders / Dissociation / /

MedicalTreatment

surgery / /

Organization

FDA / /

/

Product

Soft Gelatin Capsules / Digoxin / tamsulosin / testosterone / polyethylene glycol / DOSAGE AND ADMINISTRATION The capsules / Study / Soft Gelatin Capsule / Cholestyramine / AVODART / /

Technology

alpha / Pharmacokinetics / Cancer Detection / Pharmacodynamics / /

URL

www.fda.gov/medwatch / /

SocialTag